KATHERINE CLARE: Open Payments
NPI 1780206268 · RALEIGH, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$408 in 15 payments from 11 companies in 2025. Trend: 2023 $338 · 2024 $458 · 2025 $408
Food & beverage: $408
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 1 | $140 |
| Lilly USA, LLC | 3 | $56 |
| ABBVIE INC. | 2 | $40 |
| GlaxoSmithKline, LLC. | 2 | $39 |
| ViiV Healthcare Company | 1 | $34 |
| Novo Nordisk Inc | 1 | $20 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $17 |
| PFIZER INC. | 1 | $17 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $16 |
| AstraZeneca Pharmaceuticals LP | 1 | $15 |
Products named: KEVZARA, MOUNJARO, TRELEGY ELLIPTA, APRETUDE, VRAYLAR, Wegovy, UBRELVY, XIFAXAN.
Industry payments across NC — which companies pay providers there.
